Latest Presentations November 2022 Corporate Presentation View Presentation 1.8 MB Events Nov 30 2022 | 2:30 PM EST Fireside Chat with Paul Edick, Xeris’ Chairman and CEO at Piper Sandler 34th Annual Healthcare Conference View All Events News Releases 23 Nov 2022 Xeris Biopharma Announces Research Collaboration and Option Agreement With Horizon Therapeutics plc for XeriJect™ Formulation of Teprotumumab 09 Nov 2022 Xeris Biopharma Reports Third Quarter 2022 Financial Results and Recent Events View All News Latest Quarterly Earnings Show all Q3 2022 Webcast Q3 2022 Press Release Q3 2022 Form 10-Q Featured Reports Mar 11, 2022 2021 Annual Report 1.9 MB Dec 31, 2020 2020 Annual Report 1.9 MB View All Reports
Nov 30 2022 | 2:30 PM EST Fireside Chat with Paul Edick, Xeris’ Chairman and CEO at Piper Sandler 34th Annual Healthcare Conference
23 Nov 2022 Xeris Biopharma Announces Research Collaboration and Option Agreement With Horizon Therapeutics plc for XeriJect™ Formulation of Teprotumumab
